CCCC
C4 Therapeutics Inc
NASDAQ: CCCC · HEALTHCARE · BIOTECHNOLOGY
$2.83
+10.55% today
Updated 2026-04-30
Market cap
$281.02M
P/E ratio
—
P/S ratio
7.82x
EPS (TTM)
$-1.27
Dividend yield
—
52W range
$1 – $4
Volume
3.0M
C4 Therapeutics Inc (CCCC) Financial statements
SEC filings — annual and quarterly data.
Balance sheet — annual
| Item |
|---|
| Total assets |
| Cash & equivalents |
| Current assets |
| Total liabilities |
| Current liabilities |
| Long-term debt |
| Shareholder equity |
| Retained earnings |
| Accounts receivable |
| Inventory |
| Goodwill |